-
供暖材料网加速行业数字化转型！
-
Crinetics Announces FDA Approval of PALSONIFY™ (paltusotine) for the Treatment of Adults with Acromegaly
-
Teva to Host Conference Call to Discuss Third Quarter 2025 Financial Results at 8 a.m. ET on November 5, 2025
-
Teva Releases Q3 2025 Aide Memoire
-
eXp Realty 进军韩国市场，助力经纪人真正摆脱传统模式
-
广生胶囊品牌全面升级，中国龙头携三重惊喜引领空心胶囊创新
-
Philips joins Optum Healthcare’s network as a preferred provider in the USA
-
Cloudera Integrates with Dell ObjectScale to Deliver Enterprises a Next-Generation Private AI Platform
-
Guidepoint Appoints Michael Wang as Head of China
-
eXp Realty Expands to South Korea, Offering Agents a Real Exit from the Traditional Model
-
Cloudera Helps Customers Become AI Native with Additions to Enterprise AI Ecosystem
-
Guidepoint 任命 Michael Wang 为中国区负责人
-
Over 185% Liquidity Improvements on BitMEX Derivatives Contracts Following Strategic AWS Tokyo Migration
-
Cloudera Accelerates AI and Analytics Projects with a Unified Platform for Secure, Governed, and Performant Data
-
医疗保健成为全球最具战略意义的投资：KFSHRC CEO 在 C3 日本峰会上呼吁全球合作
-
Construction Begins on Hydrogen-Based Ironmaking Plant in Linz, Austria
-
Peak XV announces Surge 11
-
Cloudera Survey Finds 96% of Enterprises Have Integrated AI Into Core Business Processes, Signaling AI Has Moved from Competitive Advantage to Mandatory Practice
-
探秘海龙阁：食品行业的品质担当
-
《大国品牌故事》——初心铸健 康责在肩
吉利控股与招商局开展战略合作 携手共促可持续发展
中国医疗器械行业协会2023产业年会盛大启幕